Some of the world’s top makers of coronavirus vaccines said that they’re already working at an accelerated pace to battle omicron, studying the new variant and aiming to adapt their products to protect against this latest mutation, Newsmax reports.
Pfizer and BioNTech said they are investigating omicron. They said that they believe their vaccine can be adapted quickly should it be needed to curb the spread.
“We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,” the companies said.
CNBC said that according to Pfizer and BioNTech, more data from lab tests is anticipated in two weeks at the outside.
“These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,” the companies said, according to the business news network’s report.
They also estimated their mRNA vaccine, administered via a series of two shots, could be adapted within six weeks and shipped within a little over three months.
Not to be outdone, Moderna, which like Pfizer has produced an mRNA vaccine administered through two doses, said it will test three booster candidates against omicron.
Meanwhile, Johnson & Johnson said it’s already testing its single-dose vax against omicron. Read more at Newsmax.
{Matzav.com}
HCQ and IVermectin work for all variants. Add a few other meds such as antibiotics, anticoagulants and you are good to go. Take 14 vaccines if you like but there’s really no need to take the risk.
How much of a financial kickback will Fauci and members of Congress be getting from these multi billion dollar pharmicutical companies?